Real-Life Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany

被引：0
|
作者：
Dworak, Markus
Gruenberger, Jean-Bernard
Bader, Giovanni
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1101-P
引用
收藏
页码：A285 / A285
页数：1
相关论文
共 50 条
  • [31] The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
    Moon, Jun Sung
    Won, Kyu Chang
    DIABETES & METABOLISM JOURNAL, 2013, 37 (01) : 36 - 39
  • [32] Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: a real-life observational study
    Viazzi, Francesca
    Ceriello, Antonio
    Fioretto, Paola
    Giorda, Carlo
    Guida, Pietro
    Russo, Giuseppina
    Greco, Eulalia
    De Cosmo, Salvatore
    Pontremoli, Roberto
    JOURNAL OF HYPERTENSION, 2018, 36 (08) : 1719 - 1728
  • [33] Impact of sleep and physical activity habits on real-life glycaemic variability in patients with type 2 diabetes
    Gauthier, Pierre
    Desir, Chesner
    Plombas, Maud
    Joffray, Eloise
    Benhamou, Pierre-Yves
    Borel, Anne-Laure
    JOURNAL OF SLEEP RESEARCH, 2023, 32 (03)
  • [34] Real-Life Use of Automated Insulin Delivery in Individuals With Type 2 Diabetes
    Fabris, Chiara
    Kovatchev, Boris
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024,
  • [35] Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: The OMEGA study
    El Ebrashy, Ibrahim
    El Kafrawy, Nabil
    Raouf, Rana
    Yousry, Diana
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [36] CHARACTERIZATION OF PATIENTS WITH TYPE 2 DIABETES Treated With Vildagliptin
    Chambel, Paula
    Marcelino, Mafalda
    Domingues, Andreia
    Vilar, Helena
    Lopes, Luis
    Paradinha, Manuel
    Lopes, Maria Santana
    Carvalho, Raquel
    Santos, Valentim
    De Castro, Joao Jacome
    ACTA MEDICA PORTUGUESA, 2011, 24 (04): : 555 - 560
  • [37] Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes-A Real-World Study (China PDS)
    Han, Ying
    Chen, Lixian
    Hu, Daqing
    Jin, Hui
    Yang, Nailong
    Shi, Xiaoyun
    Li, Quanmin
    Liang, Linlang
    Zang, Li
    Liu, Mingming
    He, James
    Mu, Yiming
    DIABETES, 2018, 67
  • [38] The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas - a randomized trial
    Gerstein, HC
    Thorpe, KE
    Taylor, DW
    Haynes, RB
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 55 (03) : 209 - 219
  • [39] Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
    Kudo-Fujimaki, Kyoko
    Hirose, Takahisa
    Yoshihara, Tomoaki
    Sato, Fumihiko
    Someya, Yuki
    Ohmura, Chie
    Kanazawa, Akio
    Fujitani, Yoshio
    Watada, Hirotaka
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (04) : 400 - 409
  • [40] Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting
    Melzer Cohen, Cheli
    Davis, Carla
    Shalev, Varda
    Chodick, Gabriel
    JOURNAL OF DIABETES, 2018, 10 (01) : 68 - 72
12345